10mg

Molecular Formula : C13 H18 Br2 N2 O

Molecular Formula : C16 H16 Cl N O2 S . Cl H

Molecular Formula : C15 2H4 H10 Cl N O2 S

Molecular Formula : C10 H12 N2 O

Molecular Formula : C16H17D3N2O7

Molecular Formula : C11H12Cl2N2O5

Molecular Formula : C26H30N2O4

Molecular Formula : C17H15D6NO

Molecular Formula : C33 2H6 H30 N2 O4

Molecular Formula : C32 2H6 H28 N2 O5

Molecular Formula : C31H29BrN2O2

Molecular Formula : C13H18N2OS

Molecular Formula : C17 H30 O4

Molecular Formula : C20 H23 N O4 . Cl H

Molecular Formula : C13H13D5Br2N2O

Molecular Formula : C10H18ClNOS

Rapamycin

Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II), also known as Des-γ-carboxy-prothrombin (DCP), is an abnormal form of prothrombin. Normally, the prothrombin’s 10 glutamic acid residues (Glu) in the γ-carboxyglutamic acid (Gla) domain at positions 6, 7, 14, 16, 19, 20,25, 26, 29 and 32 are γ-carboxylated to Gla by vitamin-K dependent γ- glutamyl carboxylase in the liver and then secreted into plasma. In patients with hepatocellular carcinoma (HCC), γ-carboxylation of prothrombin is impaired so that PIVKA-II is formed instead of prothrombin. PIVKA-II is considered as is an efficient biomarker specific for HCC.

Molecular Formula : C10 H10 Cl N O S

Molecular Formula : C11 H18 N4 O3

Riluzole

Molecular Formula : C6H11NO4S

Molecular Formula : C14 H20 N6 O5 S

Molecular Formula : C14 D4 H16 N6 O5 S

Molecular Formula : C15H26N6O13S

Molecular Formula : C15 DH3 H20 N6 O5 S . H S O4 . H2 S O4

Molecular Formula : C18H22N6O7S

Molecular Formula : C14 H13 N5 O2 S2

Molecular Formula : C15H12N4O4S3

Molecular Formula : C17H27N3O4S

Molecular Formula : C10H13NO2S

Molecular Formula : C6 H10 N2 O2 S

Molecular Formula : C15H17N10NaO5S3

Molecular Formula : C38 H43 F2 N6 Na O8 S2

Molecular Formula : C15H23ClN2O3

S100 protein family contains variety of members such as ββ homodimer and αβ heterodimer. It is a useful marker for monitoring brain damage and detecting secondary neurological injuries. The concentration of S100 A8/A9 hetero complex increases in blood when special diseases take places, such as rheumatoid arthritis, cystic fibrosis, multiple scerlosis, and HIV infections. S100A8/A9 protein is a potential serum marker for diagnosis of pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) or chronic pancreatitis (CP).

S100 protein family contains variety of members such as ββ homodimer and αβ heterodimer. It is a useful marker for monitoring brain damage and detecting secondary neurological injuries. The concentration of S100 A8/A9 hetero complex increases in blood when special diseases take places, such as rheumatoid arthritis, cystic fibrosis, multiple scerlosis, and HIV infections. S100A8/A9 protein is a potential serum marker for diagnosis of pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) or chronic pancreatitis (CP)

S100 protein family contains variety of members such as ββ homodimer and αβ heterodimer. It is a useful marker for monitoring brain damage and detecting secondary neurological injuries. The concentration of S100 A8/A9 hetero complex increases in blood when special diseases take places, such as rheumatoid arthritis, cystic fibrosis, multiple scerlosis, and HIV infections. S100A8/A9 protein is a potential serum marker for diagnosis of pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) or chronic pancreatitis (CP).

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.